OSRAM Opto Semiconductors Opens Last Section of New Semiconductor Plant

OSRAM CEO Martin Goetzeler and Dr. Rüdiger Müller, CEO of OSRAM Opto Semiconductors, together with Regensburg Mayor Hans Schaidinger, will today officially open the last section of the company's new semiconductor plant in Regensburg, Germany. "Since the start of construction seven years ago we have invested hundreds of millions of Euros. In this period the number of employees has increased by approximately 500 to 1500," said Rüdiger Müller. This growth has boosted capacity by almost 50%, necessitating the expansion of OSRAM Opto Semiconductors facility in Regensburg to its current-day size of nearly 600,000 square feet.

State-of-the-art facilities in Regensburg: greater capacity for greater growth.

OSRAM Opto Semiconductors is a technology and world market leader in opto semiconductors – a sector of the lighting industry for which rapid market growth is expected in the next few years. Currently, products based on this technology account for 12 percent of OSRAM's total sales. Martin Goetzeler added, "LEDs are the light sources of the future so we have every intention of expanding in this field, which is why we have invested heavily in expanding the sites in Regensburg and Penang (Malaysia)." OSRAM has also focused its resources on expanding research and development, for which investment last year alone amounted to 13 percent of the sales of opto semiconductors.

Throughout the 30-year history of OSRAM Opto Semiconductors, the company's products and technologies have garnered numerous awards. In December 2007, OSRAM Opto Semiconductors earned its highest accolades in winning the German Future Prize for technology and innovation, presented by the German President to the researchers Dr. Klaus Streubel, Dr. Stefan Illek (both of OSRAM), and Dr. Andreas Bräuer (Fraunhofer Institute for Applied Optics and Precision Engineering) for the development of thin-film technology and its application in the OSTAR® family of LEDs.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.